PATENT CLAIM ANALYSIS

Application Number: 15870349
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "015200"]

Abstract:
The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.

Claim (Index 6):
The method of  claim 2 , wherein said variant of albumin has a longer serum half-life than an albumin having the sequence of SEQ ID NO: 2.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 86.0
- Lexical Diversity: 1.34615
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13504326', '13640235', '13463944', '14685112', '14385631']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8026926698718959
- 35 USC 102 Novelty (BERT): 0.6285811689106122
- Combined Prediction Score: 0.7852815197757675
- Mean Citation Score: 564.510462
- Max Citation Score: 684.62714
- Similarity Product: 508.9441288898683

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test